LSM1
U6 snRNA-associated Sm-like protein LSm1
Also known as: CASM, LSM1_HUMAN, YJL124C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15116
- Gene
- LSM1
- Ensembl
- ENSG00000175324
- Chromosome
- 8
- Canonical length
- 133 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol,Cytoplasmic bodies
OverviewNCBI Gene
This gene encodes a member of the LSm family of RNA-binding proteins. LSm proteins form stable heteromers that bind specifically to the 3'-terminal oligo(U) tract of U6 snRNA and may play a role in pre-mRNA splicing by mediating U4/U6 snRNP formation. Increased expression of this gene may play a role in cellular transformation and the progression of several malignancies including lung cancer, mesothelioma and breast cancer. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
133 residues, UniProt reviewed canonical sequence.
>O15116|LSM1
1 MNYMPGTASL IEDIDKKHLV LLRDGRTLIG FLRSIDQFAN LVLHQTVERI HVGKKYGDIP
61 RGIFVVRGEN VVLLGEIDLE KESDTPLQQV SIEEILEEQR VEQQTKLEAE KLKVQALKDR
121 GLSIPRADTL DEYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LSM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 57 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 57 nTPM
- blood vessel: 50 nTPM
- kidney: 48 nTPM
- midbrain: 42 nTPM
- skeletal muscle: 42 nTPM
- adrenal gland: 40 nTPM
Single-cell type
- esophageal apical cells: 202 nCPM
- esophageal suprabasal cells: 189 nCPM
- platelets: 185 nCPM
- extravillous trophoblasts: 184 nCPM
- megakaryocytes: 173 nCPM
- oocytes: 138 nCPM
Immune cell
- basophil: 162 nTPM
- plasmacytoid DC: 111 nTPM
- eosinophil: 105 nTPM
- T-reg: 82 nTPM
- non-classical monocyte: 79 nTPM
- total PBMC: 79 nTPM
Brain region
- thalamus: 21 nTPM
- cerebellum: 20 nTPM
- hypothalamus: 20 nTPM
- choroid plexus: 19 nTPM
- midbrain: 19 nTPM
- medulla oblongata: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LSM1.
Disease | AllUniProt
Conditions LSM1 is implicated in, by any mechanism.
- FICUS syndrome (FICUS) MIM:621193
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 26 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Global developmental delay
- FICUS syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- deadenylation-dependent decapping of nuclear-transcribed mRNA
- histone mRNA catabolic process
- mRNA processing
- negative regulation of neuron differentiation
- neuron differentiation
- RNA splicing
- RNA splicing, via transesterification reactions
- stem cell population maintenance
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LSM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LSM1 as an antibody target. Whether an autoantibody or antibody against LSM1 could matter depends on whether native LSM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LSM1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LSM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...